-The United Nations The United Nations health agency today released new treatment guidelines for the almost 20 million children under the age of five worldwide who have severe acute malnutrition, including options for allowing them to recover at home, as well as treating those with HIV. "The guidelines are critical because many national health plans currently overlook children with severe acute malnutrition. This can be fatal. If these children don't get the...
More »SEARCH RESULT
Tuberculosis gains at risk due to millions of missed patients, drug resistance –UN report
-The United Nations Treatment has saved the lives of more than 22 million people with tuberculosis (TB), according to a new report by the United Nations health agency that also reveals that the number of deaths from the disease fell to 1.3 million last year. The Global Tuberculosis Report 2013, published today by the World Health Organization (WHO), confirms that the world is on track to meet the Millennium Development Goals (MDGs)...
More »UN agency reports ‘dramatic’ progress on reducing new HIV infections
-The United Nations The rate of new HIV infections fell by one-third over the past decade due to increased spending and effective treatment, the United Nations agency leading the global HIV/AIDS response today reported. The Joint UN Programme on HIV/AIDS (UNAIDS) estimated that 2.3 million adults and children were newly infected with HIV in 2012, a figure that represents a 33 per cent reduction in annual new cases compared to 2001. In the...
More »Calling big pharma’s bluff -Dwijen Rangnekar
-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...
More »Right to affordable drugs upheld: activists-Aarti Dhar
-The Hindu "The court has recognised the right of patients to access affordable medicines over profits for big pharma companies" It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis' appeal for patent for its anti-cancer medicine imatinib mesylate or Gleevec. "We are happy that the apex court has recognised the right of patients to access affordable medicines over profits...
More »